Bidirectional interactions between diabetes and Alzheimer's disease

Area of Science:

• Neuroscience
• Endocrinology
• Gerontology

Background:

• Clinical studies link diabetes mellitus to increased risk of Alzheimer's disease (AD) and neurodegeneration.
• The precise mechanisms mediating the diabetes-AD association remain incompletely understood.
• Both conditions exhibit bidirectional influences on each other's pathological pathways.

Purpose of the Study:

• To elucidate the intricate mechanisms connecting diabetes and Alzheimer's disease (AD).
• To explore the potential role of a unifying "Factor X" in mediating neurodegeneration.
• To identify novel therapeutic targets for neurodegenerative diseases linked to metabolic dysfunction.

Main Methods:

• Review of clinical studies and molecular mechanisms.
• Analysis of how diabetes impacts vascular function, glucose metabolism, insulin signaling, and amyloid-beta (Aβ)/tau pathways.
• Examination of AD's influence on systemic glucose regulation and potential Aβ level alterations.

Main Results:

• Diabetes contributes to neurodegeneration via vascular, metabolic, and insulin signaling alterations, alongside modified Aβ/tau metabolism.
• Alzheimer's disease impacts glucose metabolism through behavioral, hypothalamic, and frailty changes, potentially affecting peripheral Aβ levels.
• Hypoglycemia during diabetes treatment may exacerbate neurodegeneration, creating a detrimental cycle.

Conclusions:

• A complex interplay exists between diabetes and AD, fostering a vicious cycle of neurodegeneration.
• Identifying the underlying "Factor X" is crucial for understanding the bidirectional relationship and developing targeted therapies.
• Targeting "Factor X" presents a promising strategy for neurodegeneration treatment, potentially addressing both diabetes and AD comorbidities.